c hristianbergaustelosmedtechcom 070 293 50 40 Q2 2017 Report Short Facts Elos Medtech Elos Medtech AB is listed on Nasdaq OMX Stockholm AB since 1989 Global sourcing at 5 ID: 1045975
Download Presentation The PPT/PDF document "Christian Bergaust CFO" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Christian BergaustCFOchristian.bergaust@elosmedtech.com070 293 50 40 Q2 2017 Report
2. Short Facts Elos MedtechElos Medtech AB is listed on Nasdaq OMX Stockholm AB since 1989.Global sourcing at 5 production sites:Sweden, Skara and TimmersdalaDenmark, GörlöseChina, TianjinUSA, MemphisNumber of employees: 522Medical device customers world-wideCertifications: ISO 13485, ISO 9001, ISO 14001, ISO 17025 in compliance with the requirements within MDD 2007/47/EC and registered by FDA (21 CFR 820)
3. Customised solutionsTime to marketMedical device competenceIncreased efficiency & effectivenessLead timeQualityOEM productsTotal commitmentSolution Partner for the medtech industry
4. Elos Medtech Complete Performance™Solution partner for the medtech industryThe unbroken chain from design and manufacturing, to packaging, distribution and logistics.
5. Quarterly growth (MSEK)Quarterly growth from July 2016
6. Summary 2017 Q2 Sales 155,6 MSEK (151,6)EBITDA 26,6 MSEK (29,4)EBIT 13,5 MSEK (16,0)Operating margin 8,7% (10,6)Result after financial net 5,9 MSEK (14,5)GeographiesAsia and Sweden strong performance in Q2. Denmark is stable. US and orthopedics down vs. Q2 in 2016, but performance is improving.
7. Increased resourcing in sales and production China sales initiative OMTEC EMOPEX Groupapr-junapr-junjan-junjan-junjul-junjan-dec 20172016201720162016/172016Nettoomsättning, mkr155,6151,6296,5292,0556,5552,0Tillväxt, %*2,69,01,519,41,09,6EBITDA, mkr26,529,453,454,895,997,3EBITDA, %17,019,418,018,817,217,6EBIT, mkr13,516,026,828,041,542,7EBIT, %8,710,69,19,67,57,7Resultat efter finansiella poster, mkr5,914,515,521,332,137,9Resultat efter skatt, mkr4,910,212,115,123,526,4Resultat efter skatt per aktie, kr0:811:692:002:493:884:37*Incl. acquisition of Onyx in 2015
8. Markets we serveShare of SalesMarket TrendOur Trend Y/YDental Implant Systems36%+Diagnostics5%+Hearing Device & Vibration13%=Orthopedics29%+Other Medical Areas17%+
9. MarketsPositive development in Dental Implant Systems, Diagnostics and Other Medical AreasOrthopedics is recoveringNet Sales Marketsapr-junapr-junjan-junjan-junjul-junjan-dec MSEK20172016201720162016/172016Dental Implant Systems54,049,9105,586,1190,5171,1Diagnostics9,48,815,817,028,529,7Hearing Device & Vibration20,722,239,244,075,380,1Orthopedics45,949,284,999,9167,2182,2Other Medical Areas25,621,551,145,095,088,9Total nettoomsättning155,6151,6296,5292,0556,5552,0
10. Markets we serveDental Implant SystemsImplants, prosthetics and instrument with complicated geometries and surface structuresOrthopedicsImplants, screws, plates, pins and wires, and related instruments such as drills and other surgical instrumentsDiagnosticsDetails and components used in tests of allergies, autoimmune diseases and similar types of analysis
11. Markets we serveHearing Device & VibrationBone-anchored hearing implants, components for traditional hearing aids and products for advanced technical solutions within vibration and soundOther Medical AreasSmall plastic details and components with extreme tolerances within cardiac rythm management, neurosurgery and radiation oncology.Components for multi-injection systems for diabetes treatment
12. InstrumentsImplants DiagnosticsProducts
13. Long-term strategy for growthOur objective is to build up a leading global group supplying as a contract manufacturer to selected segments within the medical device sector.Complement with own products This position should be obtained through organic growth and acquisitions. Complementary acquisitions to strengthen our market position and develop our customer base.Organic growth trough: Increased capacityIncreased efficiencyIntroduction of new own products
14. Continued development of own productsElos Accurate® A comprehensive digital dentistry solution based on reducing complexity for dental laboratories and prosthetic active dentistsThe components are integrated into the scanner software (3shape, Exocad and DentalWings)Torque Wrench
15. Own products – New product launch Launched new products in the Elos Accurate family in Q3 and Q45 new HC in sales recruited YTD Sales through distributors
16. Elos Medtech Complete Performance™ and the automated factoryWe have invested in automation, and streamline processflowsWe serve the customer through the product lifecycle fromR&DRegulatoryValidationsProduction of parts or complete productsDelivery Dock to stockVMIClean roomSterile solutions
17. We are well positioned for growth We are equipped for further growth: “World class” quality Strong productivity developmentCapacity for growthContinually advance manufacturing methodsBroadening our expertise in new techniquesOur market is consolidatingGlobalizationOEM solutions within dental implants and spine
18. Questions ?